Lineage Cell Therapeutics Inc
(STU:BT3)
€
0.95
+0.031 (+3.39%)
Market Cap: 244.93 Mil
Enterprise Value: 202.38 Mil
PE Ratio: 0
PB Ratio: 4.69
GF Score: 77/100 Lineage Cell Therapeutics Inc (STU:BT3) Transcripts
- 1